Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

22
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

19
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

27
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
27
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

32
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Long-term neurological outcome after hematopoietic stem cell transplant in juvenile Krabbe disease.

Journal of neurology·2026
Same author

β-ureidopropionase deficiency mimicking Leigh syndrome associated with methylmalonic aciduria.

BMJ case reports·2026
Same author

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

American journal of human genetics·2026
Same author

Neurological manifestations and genotype-phenotype correlations in <i>NDUFAF6</i>-associated mitochondrial disease.

Brain communications·2026
Same author

Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain-expressed sodium channelopathies.

Epilepsia·2026
Same author

Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Mitochondrial dysfunction in central nervous system white matter disorders.

Laia Morató1, Enrico Bertini, Daniela Verrigni

  • 1Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Center for Biomedical Research on Rare Diseases (CIBERER), ISCIII, Spain.

Glia
|May 29, 2014
PubMed
Summary

Mitochondrial defects are implicated in neurodegenerative diseases affecting white matter. Research highlights diagnostic tools like MRI and genetic sequencing for understanding and treating these complex conditions.

Keywords:
MRISDHAF1leukoencephalopathymitochondriamyelin

More Related Videos

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

1.9K

Related Experiment Videos

Last Updated: Apr 29, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

1.9K

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mitochondrial dysfunction is a key factor in neurodegenerative diseases, particularly those affecting central nervous system (CNS) white matter like multiple sclerosis.
  • Mitochondrial leukoencephalopathies, a group of disorders affecting mitochondrial oxidative metabolism, exemplify the critical role of mitochondria in white matter health.

Purpose of the Study:

  • To review current knowledge on the pathogenesis and genetics of mitochondrial leukoencephalopathies.
  • To outline diagnostic clues for various forms of mitochondrial diseases.
  • To emphasize the utility of advanced technologies in understanding and treating these disorders.

Main Methods:

  • Review of current scientific literature on mitochondrial diseases and neurodegeneration.
  • Analysis of diagnostic approaches, including magnetic resonance imaging (MRI).
  • Discussion of novel technologies like whole-exome sequencing for gene identification.

Main Results:

  • Mitochondrial diseases are clinically and genetically heterogeneous due to dual genetic control (nuclear and mitochondrial DNA).
  • Magnetic resonance imaging (MRI) is valuable for differentiating specific mitochondrial leukoencephalopathies, such as those with succinate dehydrogenase complex assembly factor 1 (SDHFA1) defects.
  • Emerging technologies are expected to uncover new molecular causes and improve diagnostic capabilities.

Conclusions:

  • Understanding the pathogenesis and genetics of mitochondrial leukoencephalopathies is crucial for diagnosis and treatment.
  • Advanced imaging and genetic sequencing techniques offer promising avenues for identifying novel etiologies and improving patient care.
  • While current treatments are largely palliative, novel gene and pharmacological therapies are under development, offering hope for both primary and secondary mitochondriopathies.